Gene expression studies have revealed diagnostic profiles and upregulation of specific pathways in many solid tumors. Some gene-expression signatures are already used as predictors of relapse in early breast cancer patients. The explosion of new information in gene expression profiling could potentially lead to the development of tailored treatments in many solid tumors. In addition, many studies are ongoing to validate these signatures also in predicting response to hormonal, chemotherapeutic, and targeted agents in breast cancer as well as in other tumors. This book has been carried out with the aim of providing readers a useful and comprehensive resource about the range of applications of microarray technology on oncological diseases. The book is principally addressed to resident and fellow physicians, medical oncologists, molecular biologists, biotechnologists, and those who study oncological diseases. The chapters have been written by leading international researchers on these topics who have prepared their manuscripts according to current literature and field experience with microarray technology.
|Titolo:||Diagnostic, Prognostic and Therapeutic Value of Gene Signatures|
|Data di pubblicazione:||2012|
|Citazione:||Russo, A., Iacobelli, S., & Iovanna, J. (2012). Diagnostic, Prognostic and Therapeutic Value of Gene Signatures.|
|Appare nelle tipologie:||7.1 Curatela|